Regional research offices
Chuck Howard - Patient story
Julie Randall - Patient story
Tara Foote - Provider story
The purpose of this study is to determine which combination of Nivolumab plus either Rucaparib, Docetaxel, or Enzalutamide is the most effective in...
Inclusion Criteria:Histologically or cytologically confirmed adenocarcinoma of the prostate withoutsmall cell or signet cell featuresAsymptomatic...
This is a multicenter phase IIb study to evaluate the efficacy and tolerability of ModraDoc006 in combination with ritonavir (denoted...
The main purpose of this study is to compare the overall response rate (ORR) and overall survival (OS) of NKTR-214 combined with nivolumab to that...